drug discovery

Peptides

AI Rewrites the Peptide Drug Pipeline

Three recent papers show machine learning moving from hype to workflow in peptide therapeutics — compressing discovery cycles and flagging safety risks earlier. Here's what changes for a field bottlenecked by synthesis and red-cell toxicity.

Peptides

The Next Generation of GLP-1s: PYY Analogs, AI-Designed Molecules, and Weekly Insulin

Semaglutide and tirzepatide rewrote the metabolic playbook. The pipeline behind them is already bifurcating — and what arrives next will look less like one blockbuster shot and more like a stack.